Discrimination between ulcerative colitis and Crohn's disease using phage display identified peptides and virus-mimicking synthetic nanoparticles-Reference-Cited by-同舟云学术

Discrimination between ulcerative colitis and Crohn's disease using phage display identified peptides and virus-mimicking synthetic nanoparticles

Published:2017-08 Issue:6 Volume:13 Page:2027-2036
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Facchin Sonia,Digiglio Liboria,D'Incà Renata,Casarin Elisabetta,Dassie Elisa,Dettin Monica^ORCID,Zamuner Annj,Buda Andrea,De Boni Michele,Della Libera Duilio,D'Urso Alessandra,Sturniolo Giacomo Carlo,Morpurgo Margherita^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference38 articles.

1. European consensus on the histopathology of inflammatory bowel disease;Magro;J Crohns Colitis,2013

2. Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling;Sipos;Dis Markers,2011

3. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study;Cleynen;Lancet,2016

4. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis;Eggena;J Immunol,1996

5. The status of diagnostic markers for inflammatory bowel disease;Beniwal;Curr Gastroenterol Rep,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel mertansine conjugate for acid-reversible targeted drug delivery validated through the Avidin-Nucleic-Acid-NanoASsembly platform;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11

2. Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases;Molecules;2024-06-25

3. Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly;Biomaterials;2023-12

4. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease;Journal of Materials Chemistry B;2022

5. Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model;ACS Nano;2019-03-18